GRI Bio, Inc. (GRI), a biotechnology company, Tuesday announced that it has regained compliance with Nasdaq's minimum bid price rule.
The company received official notice from The Nasdaq Stock Market on March 10, confirming that it meets the requirements under Listing Rule.
GRI Bio is currently trading at $6.35, down $0.15 or 2.31 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.